Clinical Trial Update: Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study [Phase 3]

View source ↗

Summary

Phase 3 trial update for pradefovir in chronic hepatitis B patients; status not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pradefovir (pradefovir)

Snippet

Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Conditions: Chronic Hepatitis b | Phase 3 | Status: UNKNOWN